The next salvo in generics vs Pharma, following what occurred in HIV medications over the last decade, may well be these Hepatitis C meds.
A topic we’ve discussed a bit here and there, the 0.7% of GNI for foreign aid that developed countries have roundly endorsed, but rarely met. This is a bit of good news on that front.
Nice opinion on another recurrent policy issue, that of food aid and the limitations that American law place on American aid that prevent it from being optimally efficient.
Straightforward – budget analysis for the coming year. Rather dry, but important.
